Nursing research informs response to COVID-19 pandemic

PHILADELPHIA (April 27,2020) — Nursing research has an important influence on evidence-based health care practice, care delivery, and policy. Two editorials in the journal Research in Nursing & Health, by researchers at the University of Pennsylvania School of Nursing (Penn Nursing), explore how nursing research has been paramount in dealing with the emerging coronavirus pandemic.…

Details

Connecting the dots between heart disease, potential for worse COVID-19 outcomes

ROCHESTER, Minn. — People with certain heart diseases may be more susceptible to worse outcomes with COVID-19, but the reason why has remained unknown. New research from Mayo Clinic indicates that in patients with one specific type of heart disease obstructive hypertrophic cardiomyopathy (HCM) the heart increases production of the ACE2 RNA transcript and the…

Details

ISSCR 2020 Virtual Meeting registration open

Skokie, IL — The International Society for Stem Cell Research has transformed its annual scientific meeting into a virtual experience, bringing the global stem cell community together to share knowledge, collaborate, and network. Registration is now open. The ISSCR 2020 Virtual Meeting, cosponsored by the Harvard Stem Cell Institute (HSCI), will deliver a comprehensive scientific…

Details

New findings on hepatitis C in infants can lead to improved treatments

Only about five per cent of the babies born to mothers with hepatitis C are themselves infected by the disease. A possible reason for this low figure is that the baby’s immune system has already destroyed the virus before birth. A new study from researchers at Karolinska Institutet published in the journal Gut reveals clear…

Details

Herpes virus decoded

Until now, scientists had assumed that there are about 80 so-called open reading frames (ORFs) in the genome of herpes simplex virus 1 (HSV-1). These are the locations in the genome where the information in the DNA is read and translated into proteins. It is now clear that there are a lot more — namely…

Details

MD Anderson and Ipsen advance new therapy with potential benefit for underserved patients with lung and ovarian cancers

HOUSTON — In a first-time disclosure of IPN60090, a small-molecule inhibitor of the metabolic enzyme glutaminase (GLS1), researchers from The University of Texas MD Anderson Cancer Center’s Therapeutics Discovery division and Ipsen Biopharmaceuticals reported the preclinical discovery and early-stage clinical development of this novel drug. IPN60090, now under investigation in a Phase I trial, may…

Details

Can Antibody Tests Help End the Coronavirus Pandemic?

A survey of New Yorkers last week found that one in five city residents carried antibodies to the new coronavirus — and in that, Gov. Andrew M. Cuomo saw good news. If so many had been infected and survived, he reasoned, the virus may be far less deadly than previously thought. But many scientists took…

Details

Needing At-Home Workers, Call Centers Turn to People With Disabilities

A workplace injury two decades ago when she was newly pregnant left Robin Irvin with neuropathy in her left leg and without a functioning bowel or bladder. She has been living on disability benefits since. Now as the coronavirus pandemic upends the economy, Ms. Irvin, 48, has found a way to get back into the…

Details

32 Days on a Ventilator: One Covid Patient’s Fight to Breathe Again

HINGHAM, Mass. — “Is he going to make it?” Kim Bello asked, clutching her phone, alone in her yard. She had slipped outside so her three children, playing games in the living room, could be shielded from a wrenching conversation with a doctor treating her husband, Jim. For two weeks, he had been battling the…

Details